ARCHIVES

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

NIH Study Confirms Male Risk Factors For Breast Cancer

February 28, 2014

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS.

February 15, 2002